Načítá se...
Neuropathology and Amyloid-β Spectrum in a Bapineuzumab Immunotherapy Recipient
The field of Alzheimer’s disease (AD) research eagerly awaits the results of a large number of Phase III clinical trials that are underway to investigate the effectiveness of anti-amyloid-β (Aβ) immunotherapy for AD. In this case report, we review the pertinent clinical history, examine the neuropat...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3172868/ https://ncbi.nlm.nih.gov/pubmed/21263194 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-2011-101809 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|